Connection

Mark Rubinstein to Rituximab

Back to Details
This is a "connection" page, showing publications Mark Rubinstein has written about Rituximab.
Mark Rubinstein
Connection Strength
0.128
Rituximab
  1. A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses. J Biol Chem. 2016 Nov 11; 291(46):23869-23881.
    View in: PubMed
    Score: 0.128
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.